Skip to main content
. 2016 Jun 21;7:115. doi: 10.3389/fgene.2016.00115

Table 5.

Summary of disease-related DNMT and TET mutations.

Protein Disease Alteration Reference
DNMT1 Hereditary sensory autonomic neuropathy with dementia and hearing loss (HSAN1E) Y495C, Y495H, D490E-P491Y Klein et al., 2011, 2013
DNMT1 Autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN) A570V, G605A, and V606F Winkelmann et al., 2012
DNMT3A Acute myeloid leukemia (AML) myelodysplastic syndrome (MDS) R882 and frameshift, nonsense and splice site mutations Ley et al., 2011;
Walter et al., 2011
DNMT3A Overgrowth syndrome Mutations interfere with domain–domain interactions and histone binding Tatton-Brown et al., 2014
DNMT3B Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF) syndrome Mutations in catalytic domain Hansen et al., 1999;
Xu et al., 1999
TET1 AML Ten-eleven translocation that gives rise to a MLL-TET1 fusion Lorsbach et al., 2003
TET2 AML, MDS, and myeloproliferative neoplasms Mutations mostly in catalytic domain Abdel-Wahab et al., 2009